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Background: The gold standard screening method of hyperoxaluria in children is using 24-hour urine collection.
Urine collection may be cumbersome and challenging for children. Reference intervals (RI) of oxalate for the
Pakistani population are not readily available. Therefore we aimed to determine the oxalate to creatinine ratio
(Ox: Cr) for Pakistani children <6 years of age.
Materials and Methods: A cross-sectional study was conducted at Aga Khan University from June 2018 to October
2019. Random urine samples from apparently healthy children < 6 years were collected and stored at -30◦ C until
analysis after adding 6M HCl. Oxalate was measured on Micro lab 300 using a kit based on oxalate oxidase
principle, while creatinine was measured by kinetic Jaffe reaction. Data was analyzed by EP evaluator and SPSS
23. Ox: Cr ratio was calculated and reported with 90% confidence interval (CI) and interquartile range (IQR).
Results: The mean age of study subjects (n=120) was 29 ±22.3 months with an M: F ratio of 1:1. Children of
various ethnicities were included from all over Karachi. The majority of the subjects were Urdu speaking
(37.5%). Median Ox: Cr was 0.13(0.10). No significant difference was noted in the median Ox: Cr ratio between
various ethnicities (p>0.05). It was significantly different in group I to V which was 0.25 (IQR: 0.06), 0.19 (IQR:
0.11), 0.15 (IQR: 0.04), 0.11 (IQR: 0.06) and 0.08 (IQR: 0.04) respectively (pvalue <0.001).
Conclusion: The established RIs of Ox: Cr ratio was 0.05-0.34 (90% CI). Ox: Cr ratio showed a declining trend with
age. Large scale reference interval studies are encouraged, taking diet and age into consideration.

1. Introduction
Oxalate is a highly insoluble end product of ascorbic acid and amino
acids glycine, serine, and hydroxyproline in humans. It is mainly
excreted via kidney in the form of calcium salt, with a tendency to
crystallize in the renal tubules. Increase urinary oxalate excretion
(Hyperoxaluria) can result from inherited disorders of oxalate meta
bolism, intestinal diseases or oxalate rich diet. The overproduction of
oxalate in the liver results in increased excretion by the kidney which
can lead to nephrocalcinosis, urolithiasis and even chronic kidney dis
ease [1].

Reference intervals (RI) of oxalate for Pakistani population are not
readily available [2] and the values used by most labs are usually taken
from the literature from studies mainly performed on Caucasian or from
manufacturer package insert of oxalate reagent kits. RI of an analyte
assist the clinician in differentiating between health and disease [3]. It is
established by testing healthy population and figuring out what appears
to be “normal” for them after defining the reference population demo
graphically. Careful determination and verification or validation of RI
by the laboratory for use is important to ensure proper utility.
Children with recurrent stone formation need comprehensive meta
bolic evaluation for serum and urine chemistries and chemical
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Fig. 1. Overall distribution of urinary oxalate levels (1a) and Ox:Cr ratio (1b) in apparently healthy children less than six years of age (n = 120).

composition of stone to identify the factors predisposing to stone for
mation [4,5]. In this regard, undifferentiated hyperoxaluria is seen in up
to 43% of Pakistani pediatric stone formers [6]. The interpretation of
biochemical information is critical for proper diagnosis and hence
management protocol for the patient. Therefore, locally derived RI are
needed for diagnosis and also for monitoring patient [7]. However, it is
troublesome and inaccurate to collect 24-h urine volumes in infants and
toddlers, as they do not void spontaneously. In children <6 years, urine
collection is usually performed by bladder catheterization, which is an
invasive procedure and increases the risk of urinary tract infection.
Urinary oxalate measurement in children is important for assessing
inherited disorders of oxalate metabolism as they usually manifest in
early childhood and determining population specific RI of oxalate in
spot urine specimen is expected to help in diagnosis and management of
inherited disorders of oxalate metabolism. Therefore, we aim to deter
mine the spot urine oxalate to creatinine reference interval in children
under 6 years of age for our population.

Fig. 2. Box and whisker plot depicting declining trend of Ox:Cr with advancing
age of children (age range <6 years).

2. Materials and methods

Siemens Diagnostic, USA. Samples were analyzed in batches with
quality control specimen for validating the results. Oxalate to creatinine
ratio (Ox:Cr) was calculated. Clinical Laboratory of Aga Khan University
Hospital is accredited by College of American Pathologist, USA.
Data was analyzed by EP evaluator and SPSS 23. Subjects were
categorized based on ages into five groups. Group 1 (0–6 month), Group
2 (6 mon-1 year), Group 3 (1–2 year), Group 4 (2–4 year) and Group 5
(4–6 year). Descriptive data was analyzed for frequencies and median
with IQR. P value < 0.05 was taken as statistically significant.
Our study has been reported in line with the STROCSS criteria [8].
Our study was registered in ClinicalTrials.gov with registration ID:
NCT04756024 publicly accessible via:
https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?
sid=S000AOWW&selectaction=Edit&uid=U0005AWR&ts=2&cx=-h
wngbp.

A cross sectional study was conducted at Section of Chemical Pa
thology, Department of Pathology and Laboratory Medicine, Aga Khan
University, Karachi from June 2018 to October 2019 after approval from
the ethical review committee of Aga Khan University Hospital. Inclusion
criteria included children less than 6 years of age, not suffering from any
illness during last two weeks and no hospitalization since last four
weeks. Children on vitamins or with either past history of kidney stones
or family history of kidney stones were excluded. A standardized ques
tionnaire was used and recommended target sample size was calculated
using CLSI Guidelines C28-A3. Non-probability (consecutive sampling)
was done.
Parents or guardian of each reference individual were invited to
participate in the study. An explanation of the study, consent form
(written in the local language, in accordance with the guidelines of the
local ethics committee) and the procedure for participation was
explained to the parents by primary investigator. Those who consented
were provided with a container for urine collection and procedure for
collection was explained. A 5 ml random morning urine sample was
collected and stored at − 30 ◦ C until analysis after adding 6 M hydro
chloric acid.
Urinary Oxalate was measured on Micro lab 300 using a kit based on
oxalate oxidase principle by Trinity Biotech Plc, Wicklow, Ireland while
creatinine was measured by kinetic Jaffe reaction on ADVIA 1800 by

3. Results
One hundred and twenty apparently healthy subjects <6 years of age
were included. Mean age of study subjects (n = 120) was 29 ± 22.3
months, with equal gender distribution (M: F 1:1). Subjects from various
districts of Karachi were enrolled; majority were from District East
(30.8%) followed by Central (28.3%), West (21.7%), Malir (15%) and
(4.2%) from South. The study population constituted of diverse ethnic
2
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Table 1
Comparison of urinary Ox: Cr cutoffs from published literature.
Country

Study type

n

Age

Urine sample

Method

Results

India [14]

Crosssectional

208

8–15 years

24 h

Chromotropic acid reaction

Poland [15]

Crosssectional

109

6–16 years

Second morning
urine sample

NDa

Switzerland
[16]

Crosssectional

384

1 month-17
years

Second morning
urine sample

Enzymatic using oxalate oxidase

Turkey [17]

Crosssectional

953

6–15 years

Non fasting random
urine

Enzymatic using analytical procedure on
manual spectrophotometer

Current Study

Crosssectional

120

<6 years

Non fasting random
urine

Enzymatic using oxalate oxidase

0.7 mg/kg (median) 1.5 mg/kg (95th
percentile) of 24-h oxalate.
Ox/Cr 0.01(median) and 0.06 (95th
percentile)
Ox/Cr (mmol/mmol)
<12 years
0.076 (95th percentile)
Ox/Cr (mmol/mmol)
>12 years
0.051 (95th percentile)
95th percentile for Ox/Cr (mg/mg)
0–0.5 years < 0.175
0.5–1 years <0.139
1–2 years <0.103
2–3 years <0.08
3–5 years <0.064
5–7 years <0.056
7–17 years < 0.048
Ox/Cr (mg/mg) (mean ± SD)
6–9 years 0.023 ± 0.015
0.048 (95th percentile)
10–12 years 0.018 ± 0.012
0.042 (95th percentile)
13–15 years 0.016 ± 0.011
0.042 (95th percentile)
Ox/Cr (mg/mg) [median (IQR)]
0–6 months 0.25 (IQR: 0.06)
6months-1 years 0.19 (IQR: 0.11)
1–2 years 0.15 (IQR: 0.04)
2–4 years 0.11 (IQR: 0.06)
4–6 years 0.08 (IQR: 0.04)

a

ND: Not determined.

background majority being Urdu speaking (n = 45, 37.5%) followed by
Pakhtoon (n = 27, 22.5%), Punjabi (n = 24, 20%), Sindhi (n = 19,
15.8%) and Baloch (n = 5, 4.2%).
Data was not normally distributed for oxalate and Ox: Cr by Kol
mogorov test (p value < 0.05) as shown in Fig. 1a and b and therefore
median (IQR) was reported.
The overall median Ox:Cr ratio for children <6 years of age was 0.13
(0.10). At 90% CI, the RI for spot Ox:Cr ratio was 0.05–0.34. The Ox:Cr
ratio was highest in group I with a median (IQR) of 0.25 (0.06).
Declining trend of the ratio was noted for age from Group II-V with
median Ox:Cr ratios of 0.19(0.11), 0.15(0.04), 0.11(0.06) and 0.08
(0.04) respectively. Significant difference was noted in median Ox:Cr in
group I to V respectively (p-value <0.001), as shown in Fig. 2.
Differences were not significant in median (IQR) Ox:Cr between
various ethnicities (p value > 0.05)

endogenous oxalate production as well as stone progression and may
prevent them all together. Therefore, early diagnosis is essential for
proper management. After a thorough search of medical literature, no
local study was published that has established the RI of oxalate in our
population while the diagnosis of oxalosis rests on the findings of
increased urinary oxalate excretion. Studies conducted in Pakistan re
volves around calcium oxalate stones and their prevalence [13]. There
are few studies which have investigated oxalate excretion in pediatric
population. We also reviewed published literature on urinary Ox:Cr in
healthy children have using following search engines; Pubmed, Medline
and Scholar Google (Table 1) [14–17]. Results from these studies are not
consistent and variable Ox:Cr ratio are reported. This variations in uri
nary oxalate excretion in different studies, could be due to usage of
different laboratory or urine collection methods or different dietary and
life style factors. The urinary Ox: Cr ratio declines with age and shows
variability according to geographic area [18]. This validates the need of
country specific Ox:Cr ratio RI [19].
In this study, we determined values for the Ox:Cr ratio in healthy
children less than 6 years of age. Results from current study are in close
proximity to study done on children stratified in seven age groups with
age range of 1 month–17 years [16]. An inverse statistically significant
relationship between the Ox:Cr ratio and age was identified, which is
similar to what scientists have reported in healthy Turkish school chil
dren (n = 953) [17]. The strength of this study is that it included par
ticipants from different ethnic groups residing in Pakistan. However, it
cannot be applied universally. In the current study dietary habits of
children, environmental conditions, body composition were not
assessed. We propose that further studies should be conducted keeping
in view of these important parameters [20–22]. Despite all these limi
tations, a good data set of a RI for morning urine Ox:Cr ratios was
provided with this study. This could be useful for identifying patients
with Hyperoxaluria.

4. Discussion
Reference interval and cut-off constitute an essential component of a
lab report. RI in the healthy state are affected by several factors
including body size, age, ethnicity, gender, diet, environmental condi
tions and hence population specific RI are preferred as clinical decisions
are based on them. In patients with stones, urinary excretion rate of
some solutes like calcium and oxalate, is usually performed to investi
gate the underlying cause [9,10]. The precise quantification and inter
pretation of oxalate is dependent on multiple factors including body
mass, dietary habits, environmental conditions and lifestyle, which for
Pakistani are much different from the Caucasians [11] and hence the
need to establish RI for the desired population [12].
In primary hereditary Hyperoxaluria (oxalosis), stone formation
usually begins in childhood, with 65% of the cases occurring before the
age of 12 years. There is a tendency of stones to recur at intervals and
without treatment, more than 80% of the patients with oxalosis become
uremic by 20–30 years of age. Treatment with pyridoxine reduce
3
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5. Conclusion

Appendix A. Supplementary data

Based on our study findings, Ox:Cr ratio showed a declining trend
with age in children. In children <6 years of age RI for Ox:Cr was
calculated as 0.05–0.34. Interpretation of random urine Ox:Cr ratios is
challenging in children and large scale reference interval studies are
encouraged taking diet and age into consideration.
Every country should have its own normal reference values to
determine the underlying metabolic risk factor for kidney stone disease,
since regional variation in the dietary intake of proteins and other nu
trients can affect normal urinary excretion of oxalate.

Supplementary data to this article can be found online at https://doi.
org/10.1016/j.amsu.2021.102251.
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